New injection shows promise for severe eczema relief

NCT ID NCT06181435

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This large, late-stage study tested a new injectable drug called amlitelimab for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that wasn't well-controlled by creams. Nearly 600 participants were randomly assigned to receive either the drug or a placebo injection for 24 weeks to see if it could clear skin and reduce severe itching. The main goal was to see if the treatment was effective and safe compared to the placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Accel Research - Nona Pediatric Center- Site Number : 8401081

Orlando, Florida, 32829, United States
Access Dermatology- Site Number : 8401296

Bowling Green, Kentucky, 42104, United States
Advanced Research Institute - Odgen- Site Number : 8401057

Ogden, Utah, 84405, United States
AllerVie Clinical Research - Columbus- Site Number : 8401104

Columbus, Georgia, 31904, United States
Allergy & Asthma Associates of Southern California - Mission Viejo- Site Number : 8401079

Mission Viejo, California, 92691, United States
Anchor Medical Research- Site Number : 8401300

Miami, Florida, 33176, United States
Arlington Research Center- Site Number : 8401248

Arlington, Texas, 76011, United States
Bexley Dermatology Research- Site Number : 8401051

Bexley, Ohio, 43209, United States
Care Access - Arlington- Site Number : 8401134

Arlington, Virginia, 22206, United States
Care Access - Hoboken- Site Number : 8401132

Hoboken, New Jersey, 07030, United States
Care Access Research - Marriottsville- Site Number : 8401126

Marriottsville, Maryland, 21104, United States
Center for Clinical Studies - Houston - Binz Street- Site Number : 8401063

Houston, Texas, 77004, United States
Center for Dermatology and Plastic Surgery- Site Number : 8401119

Scottsdale, Arizona, 85260, United States
Clinical Research Trials of Florida- Site Number : 8401023

Tampa, Florida, 33607, United States
Clinical Science Institute- Site Number : 8401028

Santa Monica, California, 90404, United States
Columbia Dermatology & Aesthetics- Site Number : 8401166

Columbia, South Carolina, 29212, United States
Cura Clinical Research - Oxnard- Site Number : 8401142

Oxnard, California, 93030, United States
Derm Texas- Site Number : 8401217

Dallas, Texas, 75235, United States
Dermatology Associates of Plymouth Meeting- Site Number : 8401147

Plymouth Meeting, Pennsylvania, 19462, United States
Dermatology Research Associates - Los Angeles- Site Number : 8401092

Los Angeles, California, 90045, United States
Eclipse Clinical Research- Site Number : 8401158

Tucson, Arizona, 85745, United States
Equity Medical- Site Number : 8401239

New York, New York, 10023, United States
First Georgia Physician Group- Site Number : 8401190

Fayetteville, Georgia, 30214, United States
Health Concepts- Site Number : 8401059

Rapid City, South Dakota, 57702, United States
Investigational Site Number : 0320001

Buenos Aires, 1121, Argentina
Investigational Site Number : 0320002

Buenos Aires, 1425, Argentina
Investigational Site Number : 0320006

Rosario, Santa Fe Province, 2000, Argentina
Investigational Site Number : 0320007

Rosario, Santa Fe Province, 2000, Argentina
Investigational Site Number : 0320009

Buenos Aires, 1425, Argentina
Investigational Site Number : 0320015

Rosario, Santa Fe Province, 2000, Argentina
Investigational Site Number : 0320016

Buenos Aires, 1055, Argentina
Investigational Site Number : 0320017

Pilar, Buenos Aires, 1629, Argentina
Investigational Site Number : 0320021

Berazategui, Buenos Aires, 1886, Argentina
Investigational Site Number : 1002004

Pleven, 5800, Bulgaria
Investigational Site Number : 1002005

Sofia, 1431, Bulgaria
Investigational Site Number : 1002008

Gabrovo, 5300, Bulgaria
Investigational Site Number : 1520003

Santiago, Reg Metropolitana de Santiago, 7640881, Chile
Investigational Site Number : 1520004

Valdivia, Los Ríos Region, 5110683, Chile
Investigational Site Number : 1520013

Santiago, Reg Metropolitana de Santiago, 7500505, Chile
Investigational Site Number : 1520014

Santiago, Reg Metropolitana de Santiago, 7750495, Chile
Investigational Site Number : 1520015

Quillota, Región de Valparaíso, 2260877, Chile
Investigational Site Number : 1560001

Shanghai, 200040, China
Investigational Site Number : 1560002

Hangzhou, 310006, China
Investigational Site Number : 1560003

Wuxi, 214000, China
Investigational Site Number : 1560004

Beijing, 100191, China
Investigational Site Number : 1560005

Shanghai, 200443, China
Investigational Site Number : 1560006

Hangzhou, 310009, China
Investigational Site Number : 1560007

Jinan, 250013, China
Investigational Site Number : 1560021

Guangzhou, 510018, China
Investigational Site Number : 1560022

Chengdu, 610041, China
Investigational Site Number : 1560023

Wenzhou, 325035, China
Investigational Site Number : 1560024

Ningbo, 315010, China
Investigational Site Number : 1560025

Guangzhou, 510080, China
Investigational Site Number : 1560026

Shenyang, 110179, China
Investigational Site Number : 1560028

Zhenjiang, 212000, China
Investigational Site Number : 1560029

Hangzhou, 310014, China
Investigational Site Number : 1560030

Beijing, 100730, China
Investigational Site Number : 2030006

Prague, 160 00, Czechia
Investigational Site Number : 2030010

Olomouc, 779 00, Czechia
Investigational Site Number : 2030011

Prague, 150 00, Czechia
Investigational Site Number : 2032104

Ostrava, 702 00, Czechia
Investigational Site Number : 2032106

Kutná Hora, 284 01, Czechia
Investigational Site Number : 2080001

Aarhus, 8200, Denmark
Investigational Site Number : 2080002

Aalborg, 9000, Denmark
Investigational Site Number : 2080003

Herlev, 2730, Denmark
Investigational Site Number : 3800008

Pisa, 56126, Italy
Investigational Site Number : 3800009

Catania, 95123, Italy
Investigational Site Number : 3800013

Rome, Roma, 00133, Italy
Investigational Site Number : 3800018

Rozzano, Milano, 20089, Italy
Investigational Site Number : 3800022

Vicenza, 36100, Italy
Investigational Site Number : 3920001

Tachikawa, Tokyo, 190-0023, Japan
Investigational Site Number : 3920002

Iruma, Saitama, 350-0495, Japan
Investigational Site Number : 3920003

Kyoto, 606-8507, Japan
Investigational Site Number : 3920004

Chūō, Tokyo, 104-0031, Japan
Investigational Site Number : 3920005

Sagamihara, Kanagawa, 252-0315, Japan
Investigational Site Number : 3920006

Kobe, Hyōgo, 653-0836, Japan
Investigational Site Number : 3920008

Sapporo, Hokkaido, 064-0921, Japan
Investigational Site Number : 3920009

Chitose, Hokkaido, 066-0021, Japan
Investigational Site Number : 3920010

Miyagi-gun, Miyagi, 981-0112, Japan
Investigational Site Number : 3920011

Sendai, Miyagi, 981-3133, Japan
Investigational Site Number : 3923102

Kyoto, 602-8566, Japan
Investigational Site Number : 3923106

Mibu, Tochigi, 321-0293, Japan
Investigational Site Number : 3923107

Minato, Tokyo, 108-0014, Japan
Investigational Site Number : 3923108

Kagoshima, 890-0063, Japan
Investigational Site Number : 3923109

Habikino, Osaka, 583-8588, Japan
Investigational Site Number : 3923110

Sakai, Osaka, 593-8324, Japan
Investigational Site Number : 3923113

Yokohama, Kanagawa, 221-0825, Japan
Investigational Site Number : 3923114

Obihiro, Hokkaido, 080-0013, Japan
Investigational Site Number : 4840003

Veracruz, 91900, Mexico
Investigational Site Number : 4840005

Monterrey, Nuevo León, 64718, Mexico
Investigational Site Number : 4840009

Durango, 34000, Mexico
Investigational Site Number : 4840011

Monterrey, Nuevo León, 64460, Mexico
Investigational Site Number : 4840012

Aguascalientes, 20127, Mexico
Investigational Site Number : 6200001

Lisbon, 1998-018, Portugal
Investigational Site Number : 6200003

Porto, 4099-001, Portugal
Investigational Site Number : 6200004

Lisbon, 1649-035, Portugal
Investigational Site Number : 6200005

Lisbon, 1169-050, Portugal
Investigational Site Number : 7100001

Durban, 4058, South Africa
Investigational Site Number : 7100003

Pretoria, 0009, South Africa
Investigational Site Number : 7100004

Boksburg, 1459, South Africa
Investigational Site Number : 7100007

Johannesburg, 2196, South Africa
Investigational Site Number : 7100009

Cape Town, 7708, South Africa
Investigational Site Number : 7100010

Cape Town, 7533, South Africa
Investigational Site Number : 7100012

Durban, 3630, South Africa
Investigational Site Number : 7100015

Johannesburg, 1500, South Africa
Investigational Site Number : 7240012

Las Palmas de Gran Canaria, Las Palmas, 35010, Spain
Investigational Site Number : 7240018

Granada, 18014, Spain
Investigational Site Number : 7240029

Madrid, 28007, Spain
Investigational Site Number : 7242503

Madrid, 28046, Spain
Investigational Site Number : 7520001

Örebro, 701 85, Sweden
Investigational Site Number : 7520006

Älvsjö, 125 44, Sweden
Investigational Site Number : 7920001

Antalya, 07070, Turkey (Türkiye)
Investigational Site Number : 7920002

Istanbul, 34098, Turkey (Türkiye)
Investigational Site Number : 7920004

Kayseri, 38039, Turkey (Türkiye)
Investigational Site Number : 7920005

Istanbul, 34093, Turkey (Türkiye)
Investigational Site Number : 7920006

Istanbul, 34093, Turkey (Türkiye)
Investigational Site Number : 7920007

Samsun, 55139, Turkey (Türkiye)
Investigational Site Number : 7920011

Mersin, 33343, Turkey (Türkiye)
Investigational Site Number : 8260003

Portsmouth, Hampshire, PO3 6DW, United Kingdom
Investigational Site Number : 8260004

Leicester, LE2 0TA, United Kingdom
Investigational Site Number : 8260006

Glasgow, G3 8SJ, United Kingdom
Investigational Site Number : 8262601

London, London, City of, SE1 9RT, United Kingdom
Investigational Site Number : 8262602

London, London, City of, SE1 7EH, United Kingdom
MedPharmics - Covington- Site Number : 8401137

Covington, Louisiana, 70433, United States
Montefiore Medical Center - Moses Campus- Site Number : 8401150

The Bronx, New York, 10467, United States
Nuline Clinical Trial Center- Site Number : 8401161

Pompano Beach, Florida, 33060, United States
OmeraNY- Site Number : 8401156

Brooklyn, New York, 11220, United States
PEAK Research- Site Number : 8401083

Upper Saint Clair, Pennsylvania, 15241, United States
Pediatric Skin Research- Site Number : 8401198

Coral Gables, Florida, 33146, United States
Progressive Clinical Research - San Antonio- Site Number : 8401016

San Antonio, Texas, 78229, United States
Prolato Clinical Research Center- Site Number : 8401209

Houston, Texas, 77054, United States
Red River Research Partners- Site Number : 8401196

Fargo, North Dakota, 58103, United States
Savin Medical Group - Miami- Site Number : 8401085

Miami, Florida, 33126, United States
Sienna Dermatology- Site Number : 8401148

Missouri City, Texas, 77459, United States
Skin Care Research - Hollywood- Site Number : 8401071

Hollywood, Florida, 33021, United States
Torrance Clinical Research- Site Number : 8401027

Lomita, California, 90717, United States
Tufts Medical Center Site Number : 8401201

Boston, Massachusetts, 02111, United States
University Of Mississippi Medical Center- Site Number : 8401184

Jackson, Mississippi, 39216, United States
University of Connecticut Health Center- Site Number : 8401115

Farmington, Connecticut, 06032, United States
University of New Mexico Comprehensive Cancer Center- Site Number : 8401263

Albuquerque, New Mexico, 87102, United States
Velocity Clinical Research - Hampton- Site Number : 8401154

Hampton, Virginia, 23666, United States
Velocity Clinical Research - Springdale- Site Number : 8401153

Cincinnati, Ohio, 45246, United States

Conditions

Explore the condition pages connected to this study.

DERMATITIS ATOPIC